With delivery still the primary problem facing those trying to develop RNAi-based therapeutics, the number of researchers trying to come up with a solution keeps growing.
The latest to join the ranks is Tatiana Segura, a postdoc at the Swiss Federal Institute of Technology, who has begun work on using the block copolymers polyethylene glycol (PEG) and polypropylene sulfide (PPS) to deliver siRNA systemically.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
